Company / Interest Expense
TransMedics Group, Inc. Interest Expense History
FY2018-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$10.8M
FY2023
5-year range
$3.7M / $10.8M
FY2019-FY2023
Trend
+189.6%
vs FY2022
Sector context
#35 of 40
Health Care
What the data says
TransMedics Group, Inc.'s interest expense of $11M is lower than 87% of companies in the Health Care sector (FY2023). Interest Expense returned to growth in FY2023 after 3 years of decline, reaching $11M.
Based on SEC 10-K filings.
$11M in FY2023 with a 5-year CAGR of +31.7%.
Increased from $4M to $11M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- +39.4%
- 5-Year CAGR
- +31.7%
- 10-Year CAGR
- -
Sector benchmark
Top 13% in Health CareTop 13% of 40This company $10.8M Sector average $332.7M
▼
-96.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +31.7%, indicating consistent growth.
- In FY2023, interest expense increased 189.6% year-over-year.
- Ranks #35 out of 40 companies in the Health Care sector.
- Lowest interest expense in the period was in FY2018.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $10.8M | +189.6% |
| FY2022 | $3.7M | -3.8% |
| FY2021 | $3.9M | -2.8% |
| FY2020 | $4.0M | -8.5% |
| FY2019 | $4.4M | +60.0% |
| FY2018 | $2.7M | - |
As of FY2023 · SEC 10-K · Updated Feb 28, 2026